1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Hormonal Disorders Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Hormonal Disorders Market, United States
3.1 Hormonal Disorders Market, United States, Revenue ($m), 2018-2033
3.1.1 Thyroid Function Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Hormonal Disorders Market, United States, Volume (Units), 2018-2033
3.2.1 Thyroid Function Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Hormonal Disorders Market, United States, Average Price ($), 2018-2033
3.4 Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Hormonal Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Beckman Coulter Inc
4.2.1 Company Overview
4.3 Roche Diagnostics International Ltd
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Plc
4.5.1 Company Overview
4.6 Inova Diagnostics Inc
4.6.1 Company Overview
5 Hormonal Disorders Market Pipeline Products6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
6.1.2 VION Biosciences Acquires Ansh Labs
6.2 Equity Offerings
6.2.1 Endogenex Raises USD69.56 Million in Equity Financing
6.3 Venture Financing
6.3.1 Endogenex Raises USD88 Million in Series C Financing
7 Recent Developments
7.1 Financial Announcements
7.1.1 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings
7.2 Product News
7.2.1 Oct 21, 2024: Inception Fertility Announces the Acceptance of 36 Abstracts to be Presented at the 2024 ASRM Scientific Congress
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Hormonal Disorders Market, United States, Volume (Units), 2018-2033
Table 4: Thyroid Function Tests Market, United States, Volume (Units), 2018-2033
Table 5: Hormonal Disorders Market, United States, Average Price ($), 2018-2033
Table 6: Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2024
Table 7: Hormonal Disorders Market Pipeline Products
Table 8: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
Table 9: VION Biosciences Acquires Ansh Labs
Table 10: Endogenex Raises USD69.56 Million in Equity Financing
Table 11: Endogenex Raises USD88 Million in Series C Financing
Table 12: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Hormonal Disorders Market, United States, Volume (Units), 2018-2033
Figure 4: Thyroid Function Tests Market, United States, Volume (Units), 2018-2033
Figure 5: Hormonal Disorders Market, United States, Company Share (%), 2024